CVS Health Corporation (CVS)
$
82.52
+1.15 (1.39%)
Key metrics
Financial statements
Free cash flow per share
3.7757
Market cap
98.3 Billion
Price to sales ratio
0.2542
Debt to equity
1.0691
Current ratio
0.8034
Income quality
1.6840
Average inventory
17.4 Billion
ROE
0.0595
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
CVS Health Corporation provides a comprehensive range of health services across the United States, demonstrating its commitment to meet the diverse needs of its clientele. The company’s Health Care Benefits segment offers a variety of health insurance products, including traditional, voluntary, and consumer-directed options, aimed at employer groups, individuals, college students, part-time workers, and various other organizations such as health plans and governmental units. With a net income ratio of 0.01 reflecting its profitability margin, CVS Health showcases its financial strength through an operating income of $8,516,000,000.00 indicative of its core operational earnings. The company earned an interest income of $0.00 showcasing its financial investments and ability to generate revenue outside its primary services. Additionally, the gross profit stands at $51,401,000,000.00 highlighting the effectiveness of its core operations. In its Pharmacy Services segment, CVS Health offers pharmacy benefit management solutions, including plan design, formulary management, and specialty pharmacy services, catering to a wide range of clients from employers to individuals. This segment plays a crucial role in managing medication needs and delivering tailored health care solutions. As of December 31, 2021, CVS Health operated approximately 9,900 retail locations and 1,200 MinuteClinic facilities, further affirming its extensive presence in the health care market. Within the financial landscape, CVS Health's stock is identified with the symbol 'CVS', attracting a variety of investors. The stock is affordable at $74.92 suitable for budget-conscious investors, while its high average trading volume of 7,804,937.00 indicates strong liquidity. With a large market capitalization of $104,662,292,465.00 the company stands as a dominant player in the health services industry, contributing significantly to the overall market landscape. As it belongs to the Healthcare sector, CVS Health is instrumental in driving innovation and growth, shaping the future of health care delivery and access. This strategic positioning not only enhances its market influence but also ensures it remains a pivotal force within the evolving health care industry.
Investing in CVS Health Corporation (CVS) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as A-, with a Bullish outlook. Always conduct your own research before investing.
Analysts predict CVS Health Corporation stock to fluctuate between $43.56 (low) and $82.88 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2025-10-20, CVS Health Corporation's market cap is $104,662,292,465, based on 1,268,326,375 outstanding shares.
Compared to Eli Lilly & Co., CVS Health Corporation has a Lower Market-Cap, indicating a difference in performance.
CVS Health Corporation pays dividends. The current dividend yield is 3.23%, with a payout of $0.67 per share.
To buy CVS Health Corporation (CVS) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for CVS. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
CVS Health Corporation's last stock split was 2:1 on 2005-06-07.
Revenue: $372,809,000,000 | EPS: $3.66 | Growth: -43.61%.
Visit https://www.cvshealth.com/investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $111.25 (2022-02-08) | All-time low: $43.56 (2024-12-23).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
zacks.com
CVS Pharmacy completes the Rite Aid deal, adding 63 stores, 626 pharmacies and nine million patients to its national care network.
globenewswire.com
CVS allegedly misled investors on its Health Care Benefits segment; rising medical costs and poor forecasts led to repeated guidance cuts and stock drops.
prnewswire.com
WOONSOCKET, R.I. , Oct. 16, 2025 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced it will support simpler access to more affordable fertility treatments for all Americans through its CVS Specialty Pharmacy and make it easier to pick up fertility medication at its 9,000 community pharmacy locations.
zacks.com
CVS Health prepares Q3 results, with pharmacy performance and Aetna's progress in focus for investors.
zacks.com
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
zacks.com
Here is how CVS Health (CVS) and Alignment Healthcare (ALHC) have performed compared to their sector so far this year.
zacks.com
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
zacks.com
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
forbes.com
CVS Health has completed the acquisition of 63 Rite Aid stores in Idaho, Oregon and Washington and prescription files across 15 states that served more than 9 million customers, the drugstore chain said Wednesday.
zacks.com
In the latest trading session, CVS Health (CVS) closed at $77.9, marking a +1.51% move from the previous day.
See all news